The Potassium Chloride for Injection, cataloged under National Stock Number 6505-01-236-6345, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Consolidated Midland Corp. Government technical data includes 7 specifications, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active.
| Parameter | Value |
|---|---|
| NSN | 6505-01-236-6345 |
| Primary Part Number | NDC00223-8331-20 |
| Item Name | Potassium Chloride for Injection |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Consolidated Midland Corp |
| Status | ACTIVE |
| Administration | INTRAVENOUS |
| Primary Container Content Quantity | 20.000 MILLILITERS |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Features Provided | STERILE |
| Primary Container Type | VIAL |
| Active Medicament Medicinal Strength | 2.000 MILLIEQUIVALENTS POTASSIUM CHLORIDE PER MILLILITER |
| Total Primary Container Quantity | 25 |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Part Number | Manufacturer |
|---|---|
| NDC00223-8331-20 PRIMARY | Consolidated Midland Corp (USA) |
| Reference | Meaning |
|---|---|
| 96520 | 5/9 Secondary reference Lyphomed Inc Div of Fujisawa Usa Inc |
| NDC00469-6520-15 | 5/9 Secondary reference Lyphomed Inc Div of Fujisawa Usa Inc |
NSN 6505-01-236-6345 is a Potassium Chloride for Injection, manufactured by Consolidated Midland Corp, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-236-6345 has 1 manufacturer part number on file: NDC00223-8331-20 (Consolidated Midland Corp).
Key specifications for NDC00223-8331-20: Administration: INTRAVENOUS; Primary Container Content Quantity: 20.000 MILLILITERS; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Features Provided: STERILE. 7 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.